Get the Stockscreener App
45.05
0.01%
0.005
Vericel Corp stock is traded at $45.05, with a volume of 360.25K.
It is up +0.01% in the last 24 hours and up +8.06% over the past month.
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
See More
Previous Close:
$45.05
Open:
$46.145
24h Volume:
360.25K
Relative Volume:
0.56
Market Cap:
$2.30B
Revenue:
$292.09M
Net Income/Loss:
$21.46M
P/E Ratio:
110.12
EPS:
0.4091
Net Cash Flow:
$47.49M
1W Performance:
-3.41%
1M Performance:
+8.06%
6M Performance:
+19.02%
1Y Performance:
+13.42%
1-Day Range:
$44.69
$46.15
1-Week Range:
$43.95
$46.90
52-Week Range:
$28.95
$48.75
Vericel Corp Stock (VCEL) Company Profile
Name
Vericel Corp
Sector
Industry
Phone
(734) 930-5555
Address
64 SIDNEY ST., CAMBRIDGE, MA
Compare VCEL vs VRTX, REGN, ARGX, RVMD, ALNY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VCEL
Vericel Corp
|
45.05 | 2.30B | 292.09M | 21.46M | 47.49M | 0.4091 |
VRTX
Vertex Pharmaceuticals Inc
|
477.36 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
656.01 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
918.22 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
189.23 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
271.77 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
Vericel Corp Stock (VCEL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-17-25 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-09-24 | Initiated | Canaccord Genuity | Buy |
| Jun-20-24 | Initiated | TD Cowen | Buy |
| Jan-25-24 | Upgrade | Truist | Hold → Buy |
| Aug-08-23 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-10-22 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-09-22 | Downgrade | Truist | Buy → Hold |
| Oct-14-22 | Resumed | Stephens | Overweight |
| Jan-11-21 | Downgrade | Oppenheimer | Outperform → Perform |
| Dec-18-20 | Initiated | Stephens | Overweight |
| Sep-17-20 | Initiated | Truist | Buy |
| Oct-09-19 | Initiated | H.C. Wainwright | Buy |
| Feb-28-19 | Downgrade | Needham | Buy → Hold |
| Aug-08-18 | Reiterated | Needham | Buy |
| Jul-16-18 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Apr-04-18 | Initiated | Leerink Partners | Outperform |
| Mar-06-18 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Mar-06-18 | Reiterated | Needham | Buy |
| Mar-05-18 | Reiterated | BTIG Research | Buy |
| Jun-21-17 | Initiated | BTIG Research | Buy |
| Mar-13-17 | Reiterated | Needham | Buy |
| Dec-22-16 | Initiated | Piper Jaffray | Overweight |
| Nov-09-16 | Reiterated | Needham | Buy |
| Apr-05-16 | Downgrade | BofA/Merrill | Buy → Neutral |
| Mar-11-16 | Upgrade | Needham | Hold → Buy |
View All
Vericel Corp Stock (VCEL) Latest News
Vericel Corporation (VCEL) Stock Forecasts - Yahoo! Finance Canada
Vericel Corporation (ATQP) Q4 2023 Earnings ReportResults, Call & Slides - TipRanks
ETFs Investing in Vericel Corporation Stocks - TradingView
Vericel Corporation (VCEL) Q4 2023 Earnings ReportResults, Call & Slides - TipRanks
Vericel Corp (NASDAQ:VCEL): Strong Growth Stock With a Bull Flag Breakout Setup - ChartMill
Vericel Corp (NASDAQ:VCEL): An Affordable Growth Stock at a Reasonable Valuation - ChartMill
Vericel stock hits 52-week high at 48.41 USD By Investing.com - Investing.com South Africa
symbol__ Stock Quote Price and Forecast - CNN
VCEL Maintained by Truist Securities -- Price Target Raised to $54.00 - GuruFocus
Vericel stock hits 52-week high at 48.41 USD - Investing.com
Vericel schedules July 30 webcast for second-quarter update - Stock Titan
Vericel to Report Second Quarter 2026 Financial Results on July 30, 2026 - Yahoo Finance
Vericel Company Profile & Introduction - Moomoo
Is Vericel (NASDAQ:VCEL) Emerging As A Small-Cap Healthcare Story? - Kalkine Media
Vericel stock hits 52-week high at 47.15 USD By Investing.com - Investing.com Nigeria
Vericel stock hits 52-week high at 47.15 USD - Investing.com
Vericel Q1 2026 slides: 30% revenue growth drives guidance raise - Investing.com
VCEL News | VERICEL CORP (NASDAQ:VCEL) - ChartMill
Vericel CMO Jonathan Hopper sells $450,000 in company stock By Investing.com - Investing.com South Africa
Vericel CMO Jonathan Hopper sells $450,000 in company stock - Investing.com
Vericel CFO Joseph Mara sells $223,750 of VCEL stock - Investing.com
Vericel CFO Joseph Mara sells $223,750 of VCEL stock By Investing.com - Investing.com South Africa
Vericel chief legal officer Sean Flynn sells $684,600 in shares - Investing.com
Vericel chief legal officer Sean Flynn sells $684,600 in shares By Investing.com - Investing.com Nigeria
Form 4 Vericel Corp Ord For: 30 June By Investing.com - Investing.com Canada
Vericel (VCEL) accounting officer sells 2,732 shares, exercises options - Stock Titan
Vericel (VCEL) CMO exercises options, sells 10,000 shares under 10b5-1 plan - Stock Titan
Vericel (VCEL) Chief Legal Officer sells 15,000 shares after option exercise - Stock Titan
Vericel Corporation (VCEL) Slips 2.51%: Support and Resistance Levels in FocusRisk Reversal - dars.gov.et
Vericel Stock Is Up 10%. Here's What This $402,000 Insider Sale Really Suggests - Yahoo Finance
Form 144 Vericel Corp For: 26 June By Investing.com - Investing.com Nigeria
Vericel stock hits 52-week high at 43.57 USD - Investing.com UK
Vericel stock hits 52-week high at 43.57 USD By Investing.com - Investing.com Nigeria
15,000-Share Option Exercise Reported for Vericel (NASDAQ: VCEL) - Stock Titan
VCEL (NASDAQ) insider sale: Joseph A. Mara sold 5,000 shares for $202,500 - Stock Titan
VCEL proposed share resale and recent insider trades (NASDAQ: VCEL) - Stock Titan
[144] Vericel Corp SEC Filing - Stock Titan
Vericel Corp (NASDAQ:VCEL): A Classic Affordable Growth Stock in Biotech - ChartMill
VCEL Forecast — Price Target — Prediction for 2027 - TradingView
Vericel Corp (VCEL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Vericel Corp (VCEL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
VCEL Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Vericel (VCEL) COO exercises options, sells 10,000 shares under 10b5-1 plan - Stock Titan
Vericel (NASDAQ: VCEL) CLO exercises options and sells 15K shares - Stock Titan
VCEL Technical Analysis & Stock Price Forecast - Intellectia AI
Vericel Corp (VCEL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Vericel Corp (VCEL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Vericel Corp (VCEL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Vericel Corp (VCEL) Valuation: PE, PB & Fair Value Analysis - TradingKey
Vericel Corp (VCEL) Institutional Confidence - TradingKey
Vericel Corp Stock (VCEL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.46%
0.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):